A joint BTS-UKEMS Congress was held at Robinson College, Cambridge, from 15th - 17th April 2019

The meeting was opened by UKEMS President Karen Brown, followed by a Keynote from Stefan Platz, from AstraZeneca entitled ‘Impact of Artificial Intelligence in Understanding Toxicological Insights’. This included machine learning and deep learning, showing how these techniques can be applied to determine if an image is a dog or a muffin!

IGG hosted a session on Monday 15th April chaired by Dr Julia Kenny (GSK) & Dr Patricia Parris (AstraZeneca)

Symposium 4: New paradigms of genotoxicity safety evaluation for risk assessment

16:45 – 17:15  Bob Young (Merck, Bioreliance Testing Services)

Use of Duplex Sequencing™ for Detection of In Vivo Mutagenesis and early Preneoplastic Events as Biomarkers of Human Cancer Risk (sponsored by Merck)

17:15 – 17:45 Dr Stefan Pfuhler (P&G)

Newly Validated 3D Skin Genotoxicity Assays Improve Safety Assessments of Cosmetic Ingredients

17:45 – 18:15 Dr Giel Hendriks (Toxys)

Novel extensions of the ToxTracker genotoxicity assay to provide insight into mode of action of aneugenic and clastogenic chemicals

18:15 – 18:30 Ms Rebekah Beck (University of Manchester)

Genome-wide and gene-specific methylation assays to identify potential associations between de-methylating compounds and genotoxicity.

There were also a number of other industry-relevant talks and posters throughout the conference, and the large poster and exhibition hall was a great networking space, giving attendees from both BTS and UKEMS the opportunity to broaden their networks.

Queens’ College, Cambridge was the beautiful setting for the conference dinner, where two industrial-sponsored PhD students were awarded prizes. Congratulations Rebekah Beck and Felix Dobbs!